Home Forums Masks, Covid, Vaccines & More What Do You Need to Know About the Covid “Vaccines”? Reply To: What Do You Need to Know About the Covid “Vaccines”?

Chris
Keymaster
Post count: 309

Read about the recent FDA decision to recommend that Pfizer “to amend its Emergency Use Authorization for its COVID vaccine for children 5 through 11 years old, despite a host of objections from scientists and physicians.” See some highlights below.

Experts raised concerns over the lack of safety and efficacy data presented by Pfizer for use of its COVID vaccine in younger children, and they pointed to increasing safety signals based on reports to the Vaccine Adverse Event Reporting System (VAERS).

They also questioned the need to vaccinate children — whose risk of dying from COVID is “almost nil” — at all.

According to Dr. Meryl Nass, member of the Children’s Health Defense Scientific Advisory Panel, Pfizer once again did not use all of the children who participated in the trial in their safety study.

“Three thousand children received Pfizer’s COVID vaccine, but only 750 children were selectively included in the company’s safety analysis,” Nass said. “Studies in the 5-11 age group are essentially the same as the 12-15 group — in other words, equally brief and unsatisfying, with inadequate safety data and efficacy data, with no strong support for why this type of immuno-bridging analysis is sufficient.”

Nass said, “All serious adverse events were considered unrelated to the vaccine.”

Steve Kirsch, founder of the COVID-19 Early Treatment Fund, asked the panel how they could do a risk-benefit analysis with Pfizer’s COVID vaccine if they did not know the CDC’s VAERS under-reporting factor (URF).

Kirsch asked:

“How can you do a risk-benefit of analysis of COVID vaccines if you don’t know the URF? This is extremely, extremely important. You have been assuming it has been one. It is not one. Using a URF of 41, which is calculated using CDC methodology, we find over 300,000 excess deaths in VAERS. If the vaccine didn’t kill these people, what did?”

“How many Americans have to die before you pull the plug?” Kirsch asked.

Kirsch also questioned the panel on why Maddie de Garay’s severe adverse reaction to the Pfizer vaccine, which left her paralyzed, was not reported by the company to the FDA.

Dr. Jessica Rose, viral immunologist and biologist, told the panel EUA of biological agents requires the existence of an emergency and the nonexistence of alternate treatment.

“There is no emergency and COVID-19 is exceedingly treatable,” Rose said.

In a peer-reviewed study co-authored by Rose, myocarditis rates were significantly higher in people 13 to 23 years old within eight weeks of the COVID vaccine rollout.

In 12- to15-year-olds, Rose said, reported cases of myocarditis were 19 times higher than background rates.

“In an act of censorship, this paper has been temporarily removed and it has now been killed without criticism of the work,” Rose said, noting the timing of the removal was strange.

Rose said tens of thousands of reports have been submitted to VAERS for children ages 0 to 18.

Read the article: Breaking: FDA Panel Endorses Pfizer Shots for 5- to 11-Year-Olds, Experts Say Vaccine for Kids Is ‘Unnecessary, Premature and Will Do More Harm Than Good’

See the video of Maddie de Garay: Comcast Censors Vaccine Paralyzed 13-Year-Old Girl

Maddie de Garay volunteered for the Pfizer trial for 12–15-year-olds and received her first dose on 12/30/20 and her second dose on 1/20/21. 24-hours after her second dose she was reduced to crippling, scream-inducing pain that landed her in the emergency room.